NeuroSense reports 65% death risk reduction in ALS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. NVDA
4. MSTR
5. MU
6. DFTX
7. BAUFF
8. ICE
9. KR
10. RGA

Go back to NeuroSense reports 65% death risk reduction in ALS trial
(NASDAQ: NRSN) Delayed: 0.80 --0 (-0%)
Previous Close $0.80    52 Week High $ 
Open $0.80    52 Week Low $ 
Day High $0.80    P/E N/A 
Day Low $0.80    EPS $ 
Volume 45,960       

(NASDAQ: NRSNW) Delayed: 0.09 --0 (-0%)
Previous Close $0.09    52 Week High $ 
Open $0.09    52 Week Low $ 
Day High $0.09    P/E N/A 
Day Low $0.09    EPS $ 
Volume 280,888